nonprofit logo

The Osteosarcoma Institute Inc

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 822921815 ✦ Dallas, TX ✦ Designated as a 501(c)(3)

Overview

What is The Osteosarcoma Institute Inc?

The Osteosarcoma Institute Inc, situated in Dallas, Texas, is a dedicated nonprofit organization with a mission to significantly enhance the lifespan of patients battling relapsed and metastatic osteosarcoma. In line with this objective, the institute has executed funding agreements worth $404,411 for translational science research, with a substantial contribution of $200,000 made in 2022. This research aims to develop and implement a well-thought-out strategy, underpinned by rationality, to address this critical medical challenge. With a modest workforce of three individuals, the Osteosarcoma Institute Inc is committed to making a significant impact in the field of osteosarcoma treatment and patient care.


Official website here: www.osinst.org

Is The Osteosarcoma Institute Inc legitimate?

The Osteosarcoma Institute Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. The Osteosarcoma Institute Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $193,545
Professional Fundraising Fees: $0
Other Salaries and Wages: $164,353

For more financial information, click here


Official website here: www.osinst.org

What is the mission statement of The Osteosarcoma Institute Inc?

The Osteosarcoma Institute Inc's mission is to develop and implement a comprehensive, rational strategy aimed at significantly improving the life expectancy of relapsed and metastatic osteosarcoma patients. This organization is committed to executing this strategy effectively. In 2022, the Institute signed funding agreements totaling $404,411 for translational science grants with the University of Minnesota, with $200,000 being funded during that year.


Official website here: www.osinst.org

Who is the CEO of The Osteosarcoma Institute Inc?

Mchenry Tichenor Jr is the Institute Director of The Osteosarcoma Institute Inc.


Official website here: www.osinst.org

What is the revenue of The Osteosarcoma Institute Inc?

The Osteosarcoma Institute Inc's revenue in 2022 was $749,958.


Official website here: www.osinst.org

Who are the executives of The Osteosarcoma Institute Inc and what are their salaries?

The average compensation at The Osteosarcoma Institute Inc during 2022 was $119,299. There are 3 employees at The Osteosarcoma Institute Inc.

Here are 5 key members and their salaries:

    Lee Helman (Institute Director)
  • Compensation: $193,545
  • Related: $0
  • Other: $0

    • Mchenry Tichenor Jr (Chair Of Board Of Trustees)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Mary Katherine Clarke (Board Of Trustees)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Lisa Tichenor (Board Of Trustees)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Bret Alexander (Former Chair Of Board Of Trustees)
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.osinst.org

    Where can I find the form 990 for The Osteosarcoma Institute Inc?

    The The Osteosarcoma Institute Inc’s most recent form 990 was submitted in 2022 and can be accessed here


    Official website here: www.osinst.org

    Learn more at the official website: www.osinst.org

    Mission Statement of The Osteosarcoma Institute Inc

    The Osteosarcoma Institute is committed to devising and implementing a comprehensive, logical plan aimed at significantly enhancing the survival chances of patients diagnosed with relapsed and metastatic osteosarcoma. Through this strategy, the institute aims to make a substantial improvement in the life expectancy of affected individuals. To accomplish this mission, the Osteosarcoma Institute has secured funding for translational science grants, totaling $404,411. In 2022 alone, they allocated $200,000 towards these grants, demonstrating their dedication and financial commitment to furthering research and improving the prognosis for osteosarcoma patients in relapse or with metastatic conditions.

    Impact

    This information is meant to be a general summary of The Osteosarcoma Institute Inc. Please take the time to review official sources before making any decisions based upon the content provided here.




    Saturday, July 20, 2024

    The Osteosarcoma Institute Inc is actively working to develop and implement a comprehensive, rational strategy aimed at significantly improving the life expectancy of relapsed and metastatic osteosarcoma patients. Through funding grants totaling $404,411 with the University of Minnesota, this organization is dedicated to advancing translational science in the field of osteosarcoma research. Their mission to enhance the outcomes for individuals facing this challenging cancer highlights their commitment to making a tangible impact in the medical research community.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $7,100
  • Program Service Revenue: $0
  • Gross Receipts: $749,958

    • Assets and Liabilities:
  • Total Assets: $6,110,939
  • Total Liabilities: $14,016
  • Net Assets: $6,096,923
  • Organization Details

    Founding Year

    2017

    Principal Officer

    Mchenry Tichenor Jr

    Main Address

    3963 MAPLE AVE 390, DALLAS, TX, 75219

    NTEE Category

    Code: H05 - Medical research

    If you are a representative of The Osteosarcoma Institute Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.